| Literature DB >> 30211218 |
Du Kong1, Wei Wang2, Gang Du1, Binyao Shi1, Zhengchen Jiang1, Bin Jin1.
Abstract
BACKGROUND: Although liver retraction using n-butyl-2-cyanoacrylate (NBCA) glue has been applied to laparoscopic upper abdominal surgery in noncirrhotic patients, there is still no consensus on its safety and feasibility for cirrhotic patients. In this study, we aimed to investigate the safety and effectiveness of liver retraction using NBCA glue during laparoscopic splenectomy and azygoportal disconnection (LSD) for gastroesophageal varices and hypersplenism secondary to liver cirrhosis and portal hypertension.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30211218 PMCID: PMC6120335 DOI: 10.1155/2018/3064046
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Process of liver retraction and the operation of laparoscopic splenectomy. (a) Spraying the n-butyl-2-cyanoacrylate glue on the surface of the left lateral lobe. (b) Pressing the left lateral lobe by the laparoscopic forceps against the diaphragm. (c) A clear view of surgical field and suitable workspace after liver adhesion. (d) The splenic artery and vein were transected en bloc.
Figure 2The operation of laparoscopic azygoportal disconnection and the liver adhesion lasted until the end of the operations. (a) The stomach was pulled to the left with a sterile gauze tape. (b) A surgeon was dividing the paraesophageal venous collaterals with harmonic scalpel. (c) The distal esophagus was dissected through the hiatus, and the paraesophageal venous collaterals were divided. (d) The left lateral lobe was still attached to the diaphragm when the distal esophagus devascularization finished.
Clinical characteristics of the patients.
| Variable | NBCA group (n=22) | Non-NBCA group (n=16) | P value |
|---|---|---|---|
| Age (yrs) | 52.18±6.68 | 50.69±7.20 | 0.514 |
| Sex | 0.729 | ||
| Male | 15 | 12 | |
| Female | 7 | 4 | |
| Child-Pugh class | 1.000 | ||
| A | 13 | 10 | |
| B | 9 | 6 | |
| Etiology | 1.000 | ||
| HBV+ cirrhosis | 19 | 14 | |
| Alcoholic cirrhosis | 3 | 2 | |
| spleen diameters | 22.73±4.56 | 23.44±3.97 | 0.620 |
Perioperative parameters in two groups.
| Variable | NBCA group (n = 22) | Non-NBCA group (n = 16) | P value |
|---|---|---|---|
| Time of operation (min) | 198.86±17.86 | 217.81±20.25 | 0.004 |
| Blood loss (ml) | 159.09±56.98 | 212.50±88.51 | 0.030 |
| Postoperative hospital stay (day) | 11.14±2.01 | 11.13±1.78 | 0.660 |
| PLT counts (×109/L) | |||
| Preoperative | 48.64±13.98 | 52.44±23.33 | 0.535 |
| Postoperative day 7 | 206.09±28.90 | 227.81±73.25 | 0.213 |
| WBC counts (×109/L) | |||
| Preoperative | 3.07±0.77 | 3.22±1.65 | 0.693 |
| Postoperative day 7 | 8.85±1.30 | 9.11±2.17 | 0.648 |
| Liver adhesion time (min) | 2.46±0.46 | ||
| Complications | |||
| Pleural effusion | 2 | 1 | |
| Left subphrenic abscess | 0 | 1 |
PLT: platelet; WBC: leukocyte
Liver functions in two groups.
| Variable | NBCA group (n=22) | Non-NBCA group (n=16) | P value |
|---|---|---|---|
| ALT (unit/L) | |||
| Preoperative | 31.64±19.22 | 28.75±9.94 | 0.587 |
| Postoperative day 1 | 35.32±6.12 | 34.50±18.22 | 0.845 |
| Postoperative day 7 | 27.55±6.50 | 25.13±11.18 | 0.406 |
| AST (Unit/L) | |||
| Preoperative | 36.45±18.79 | 33.06±11.23 | 0.525 |
| Postoperative day 1 | 50.55±10.63 | 49.56±19.70 | 0.844 |
| Postoperative day 7 | 33.05±6.00 | 33.13±10.55 | 0.977 |
ALT: alanine aminotransferase; AST: aspartate aminotransferase